HSDT: Helius Medical Technologies Inc. Company Aggregate Debts

HSDT (Helius Medical Technologies Inc.) - company brandmark

Helius Medical (HSDT) maintains a high reputation among neurologists due to the safety of the PoNS platform. However, the business faces skepticism from medical professionals and complexities regarding insurance reimbursements. The model scales through device sales and a high-margin SaaS service. Total debt levels illustrate the issuer's financial stability, and 0.00 shows the current value of this metric.

Helius Medical - HSDT Company Debts (period 07/04/2022 - 10/28/2026)

Helius Medical - analytical breakdowns and key metrics (HSDT)

- price and consensus price forecast:
Market Price heliusmedical.com|HSDT - Consensus Target
- market capitalization data:
Market Capitalization Helius Medical Technologies Inc.|HSDT - Total Company Value
- book capitalization data:
Accounting Value of a Share Helius Medical Technologies|HSDT - Company Book Value|Market-to-Book Ratio heliusmedical.com|HSDT - Company Total Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Helius Medical|HSDT - Long-Term Debt to Capital|Current Liabilities to Capital heliusmedical.com|HSDT - Company Debts|Debt to Book Capitalization Ratio Helius Medical Technologies Inc.
Fundamental company analysis:HSDT Helius Medical Technologies, Inc.
Signature product of Helius Medical Technologies Inc.

This indicator measures the total volume of borrowed capital, allowing investors to assess the debt load and the risk of losing financial stability prior to the publication of financial statements. By analyzing the business's total liabilities, one can determine how effectively Helius Medical (HSDT) utilizes leverage to scale sales of its unique PoNS neurostimulators, given the company's significant pricing power in a market characterized by the inelastic demand of paralyzed patients.

Key competitors

Company Cumulative Debt Biogen Idec BIIB|Company Total Debt NBIX (Neurocrine Biosciences)|regencellbioscience.com - Company Aggregate Debts|Company Debts Axsome Therapeutics, Inc. (AXSM)|ACAD: Aggregate Debt Obligations|Company Debts XENE|Viking Therapeutics Corp (VKTX) - Company Cumulative Debt|SUPN - Company Aggregate Debts|Aggregate Debt Obligations catalystpharma.com|Denali Therapeutics Inc. - Company Aggregate Debts|Company Cumulative Debt HRMY (Harmony Biosciences Inc)|Company Debts Biohaven Pharmaceutical BHVN|Company Debts Amylyx Corp AMLX|Company Aggregate Debts TRVI (Trevi Therapeutics)|praxismedicines.com (PRAX) - Company Total Debt Obligations|AVXL: Company Total Debt|CBLL (CeriBell Inc) - Company Aggregate Debts|PRTA: Company Debts|Company Total Debt Obligations Alector Therapeutics (ALEC)|Annexon, Inc. (ANNX) - Company Total Debt|Aggregate Debt Obligations OMER (omeros.com)|Neurogene - Company Debts|Company Total Debt AC Immune S.A. ACIU|VYGR (Voyager Pharma) - Company Aggregate Debts|NMRA - Company Cumulative Debt|Company Aggregate Debts Scilex Holding Company|tevogen.com (TVGN) - Company Aggregate Debt|ACOG: Company Aggregate Debts|Company Total Debt Obligations Cognition Therapeutics Inc.|Company Aggregate Debts IKT (Inhibikase)|Company Total Debt Cassava Pharma (SAVA)|Company Aggregate Debts ASRT (Assertio)|Coya Therapeutics Inc - Company Aggregate Debts|VTGN - Company Debts|OVID - Company Debts|Company Aggregate Debts Acumen Pharma ABOS|CRVO (CervoMed Corporation) - Aggregate Debt Obligations|ATHE: Company Debts|Company Total Debt Obligations Clene Nanomedicine|Company Aggregate Debts PepGen Inc. PEPG|Company Aggregate Debt Jupiter Neurosciences, Inc. JUNS|Company Total Debt Relmada (RLMD)|Annovis Bio Corporation - Company Cumulative Indebtedness|Grace Tx (GRCE) - Company Debts|AIFF - Company Aggregate Debt|Company Aggregate Debts KLTO|Company Cumulative Debt NeuroSense Therapeutics Ltd.|RVPH (Reviva Pharmaceuticals Holdings) - Company Total Debt|Company Aggregate Debts MTVA|NeurAxis, Inc. (NRXS) - Company Debts|Aggregate Debt Obligations PASG (passagebio.com)|NEUP: Company Debts|Company Cumulative Debt Minerva Neurosciences Inc NERV|Company Aggregate Debts Athira (ATHA)|ADXN - Aggregate Debt Obligations|Company Aggregate Debts ALZN|CYCN (Cyclerion Therapeutics, Inc.) - Company Cumulative Debt|Company Debts Protagenic Therapeutics Inc.|Company Debts Pasithea|CRGT (Cortigent, Inc.) - Company Aggregate Debts|Company Total Debt Obligations Avenue Therapeutics Inc ATXI|Company Total Debt BCLI (Brainstorm Cell)|caratherapeutics.com - Company Aggregate Debts|Company Debts CHRO (Chromocell Therapeutics Corp.)|Eliem Therapeutics (ELYM) - Company Total Debt Obligations|Company Total Debt intracellulartherapies.com ITCI|LBPH (Longboard) - Aggregate Debt Obligations|Company Debts MRNS|Company Total Debt nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. - Company Aggregate Debts|Company Cumulative Debt Sage Therapeutics Inc. (SAGE)|SNPX - Company Aggregate Debts|Company Aggregate Debt Trevena Inc TRVN|Company Aggregate Debts VIGL (Vigil Neuro)|WENA - Company Total Debt Obligations|CERE (Cerevel Therapeutics, Inc.) - Company Aggregate Debts